Nov 17 (Reuters) - Hims & Hers Health ( HIMS ) has appointed Deb Autor as its first chief policy officer to lead public policy and government functions, the telehealth firm said on Monday. Autor brings more than three decades of experience, having served as the deputy commissioner for global regulatory operations and policy at the U.S. Food and Drug...

* US appeals court to weigh whether to revive more than 500 lawsuits * Lawsuits were dismissed after judge criticized the science put forward by plaintiffs * Trump administration has focused on Tylenol, merger between Kenvue ( KVUE ) and Kimberly-Clark ( KMB ) By Diana Novak Jones CHICAGO, Nov 17 (Reuters) - A U.S. appeals court is expected to...

* Retail investors show signs of caution, altering market dynamics * Vanda Research notes reduced conviction in market rallies among retail investors * BofA Securities says retail investors were net sellers for first time since late September By Suzanne McGee Nov 17 (Reuters) - Retail investors are showing signs of waning confidence in the U.S. stock market's ability to rebound,...

06:44 AM EST, 11/17/2025 (MT Newswires) -- Organon (OGN) and Shanghai Henlius Biotech said Monday that the US Food and Drug Administration has approved the biologics license application for Poherdy as an interchangeable biosimilar to Perjeta, also known as pertuzumab. The companies said Poherdy is indicated for use in combination with trastuzumab and docetaxel for the treatment of adults with...